X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (11) 11
docetaxel (10) 10
gemcitabine (10) 10
humans (10) 10
aged (9) 9
carcinoma, non-small-cell lung - drug therapy (9) 9
docetaxel/gemcitabine (9) 9
lung neoplasms - drug therapy (9) 9
aged, 80 and over (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
chemotherapy (8) 8
deoxycytidine - administration & dosage (8) 8
deoxycytidine - analogs & derivatives (8) 8
female (8) 8
index medicus (8) 8
male (8) 8
vinorelbine (8) 8
carcinoma, non-small-cell lung - pathology (6) 6
lung neoplasms - pathology (6) 6
survival rate (6) 6
taxoids - administration & dosage (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
cisplatin (5) 5
lung cancer, non-small cell (5) 5
treatment outcome (5) 5
trial (5) 5
care and treatment (4) 4
hematology, oncology and palliative medicine (4) 4
lung cancer (4) 4
paclitaxel (4) 4
adult (3) 3
age (3) 3
aged patients (3) 3
cancer (3) 3
carboplatin - administration & dosage (3) 3
clinical trials (3) 3
combination (3) 3
disease progression (3) 3
drug administration schedule (3) 3
elderly (3) 3
medicine & public health (3) 3
middle aged (3) 3
neoplasm staging (3) 3
non-small cell lung cancer (3) 3
pulmonary/respiratory (3) 3
survival (3) 3
age factors (2) 2
anemia (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
cancer research (2) 2
carboplatin (2) 2
carboplatin - adverse effects (2) 2
carcinoma (2) 2
carcinoma, squamous cell - drug therapy (2) 2
carcinoma, squamous cell - pathology (2) 2
comparative analysis (2) 2
deoxycytidine - therapeutic use (2) 2
disease-free survival (2) 2
elderly patients (2) 2
erlotinib (2) 2
erlotinib hydrochloride (2) 2
geriatric assessment (2) 2
lung cancer, small cell (2) 2
multicenter (2) 2
nsclc (2) 2
older patients (2) 2
paclitaxel - administration & dosage (2) 2
paclitaxel - adverse effects (2) 2
pharmacology & pharmacy (2) 2
phase-ii (2) 2
phase-iii (2) 2
platinum (2) 2
plus gemcitabine (2) 2
pooled analysis (2) 2
prognosis (2) 2
prospective studies (2) 2
quality-of-life (2) 2
quinazolines - therapeutic use (2) 2
stage-iiib (2) 2
2nd-line treatment (1) 1
5-fluorouracil (1) 1
activities of daily living (1) 1
adenocarcinoma (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - pathology (1) 1
analysis (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic agents - economics (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - economics (1) 1
autopsy findings (1) 1
biomarkers, tumor - blood (1) 1
breast cancer (1) 1
cancer therapies (1) 1
carcinoma, non-small-cell lung - economics (1) 1
carcinoma, non-small-cell lung - mortality (1) 1
cells (1) 1
chemotherapy toxicity (1) 1
circulating tumor cells (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical and Translational Oncology, ISSN 1699-048X, 7/2014, Volume 16, Issue 7, pp. 637 - 643
Journal Article
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 07/2012, Volume 12, Issue 1, pp. 301 - 301
Journal Article
Journal of Geriatric Oncology, ISSN 1879-4068, 2016, Volume 8, Issue 1, pp. 23 - 30
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 3/2000, Volume 11, Issue 3, pp. 367 - 371
Purpose:The objective of this study was to determine thedocetaxel MTD when combined with gemcitabine or vinorelbine in advanced breastcancer patients who had... 
Oncology | breast cancer | phase I | docetaxel + vinorelbine | Medicine & Public Health | docetaxel + gemcitabine | Breast cancer | Phase I | Docetaxel + gemcitabine | Docetaxel + vinorelbine | docetaxel plus gemcitabine | TRIAL | ONCOLOGY | docetaxel plus vinorelbine | PHASE-II | PACLITAXEL
Journal Article
Journal Article
Clinical Lung Cancer, ISSN 1525-7304, 2011, Volume 12, Issue 2, pp. 100 - 105
Journal Article
整形外科と災害外科, ISSN 0037-1033, 2015, Volume 64, Issue 1, pp. 176 - 181
近年,軟部肉腫におけるGemcitabine +... 
有害事象 | 化学療法 | Gemcitabine + Docetaxel併用療法 | 骨軟部腫瘍
Journal Article
日本泌尿器科学会雑誌, ISSN 0021-5287, 2014, Volume 105, Issue 2, pp. 43 - 46
症例は69歳男性.主訴は無症候性血尿で,腹部CTと尿管鏡にて右下部尿管の尿管癌と診断し,右腎尿管全摘術および膀胱部分切除術を施行した.病理組織学的診断はurothelial carcinoma, grade3, pT3, INFβ,... 
gemcitabine | 尿管癌 | granulocyte colony-stimulating factor | docetaxel
Journal Article
日本臨床外科学会雑誌, ISSN 1345-2843, 2017, Volume 78, Issue 5, pp. 951 - 957
Journal Article
肺癌, ISSN 0386-9628, 2001, Volume 41, Issue 6, pp. 667 - 672
Background: There are a few reports of pulmonary toxicity concerning combined chemotherapy with gemcitabin (GEM) and docetaxel (TXT). In this report, we... 
Interstitial pneumonitis | Gemcitabine | Pulmonary toxicity | Lung cancer | Docetaxel
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.